Citadel Advisors’s RAPT Therapeutics RAPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-9,072
| Closed | -$88.5K | – | 6779 |
|
|
2025
Q1 | $88.5K | Buy |
9,072
+9,059
| +69,685% | +$88.4K | ﹤0.01% | 5196 |
|
|
2024
Q4 | $158 | Buy |
+13
| New | +$158 | ﹤0.01% | 5886 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 6532 |
|
|
2024
Q2 | – | Sell |
-30,223
| Closed | -$2.17M | – | 6657 |
|
|
2024
Q1 | $2.17M | Buy |
30,223
+17,827
| +144% | +$1.28M | ﹤0.01% | 2417 |
|
|
2023
Q4 | $2.46M | Sell |
12,396
-785
| -6% | -$156K | ﹤0.01% | 2231 |
|
|
2023
Q3 | $1.75M | Sell |
13,181
-5,598
| -30% | -$744K | ﹤0.01% | 2516 |
|
|
2023
Q2 | $2.81M | Buy |
18,779
+5,948
| +46% | +$890K | ﹤0.01% | 2157 |
|
|
2023
Q1 | $1.88M | Buy |
12,831
+4,266
| +50% | +$626K | ﹤0.01% | 2595 |
|
|
2022
Q4 | $1.36M | Sell |
8,565
-7,972
| -48% | -$1.26M | ﹤0.01% | 2935 |
|
|
2022
Q3 | $3.18M | Buy |
16,537
+14,863
| +888% | +$2.86M | ﹤0.01% | 2285 |
|
|
2022
Q2 | $244K | Sell |
1,674
-7,491
| -82% | -$1.09M | ﹤0.01% | 4818 |
|
|
2022
Q1 | $1.61M | Buy |
+9,165
| New | +$1.61M | ﹤0.01% | 3248 |
|
|
2021
Q4 | – | Sell |
-1,328
| Closed | -$330K | – | 7042 |
|
|
2021
Q3 | $330K | Buy |
+1,328
| New | +$330K | ﹤0.01% | 4942 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 6962 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 6714 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 5492 |
|